An Interview with Jerome Sarris, PhD by Kirk Hamilton PA-C
N-acetylcysteine (NAC) is a sulfur containing compound that when taken orally has shown benefit in treating mood disorders, bipolar depression, schizophrenia, Trichotillomania, gambling and marijuana addiction. In this study 1500 mg twice daily over 16 weeks showed benefit in obsessive compulsive disorder (OCD) with minimal side effects (some with mild GI distress).
NAC may work by an anti-inflammatory, antioxidant effect by enhancing glutathioneand also possibly by restoring extracellular glutamate which reduces glutamine from the cell and thereby reduces impulsive glutaminergic activity which reduces OCD impulsivity. The dose should be titrated up over a 2 week period and benefit make take 3-4 months to see.
Listen to Interview
- N-acetylcysteine (NAC) Products in Prospector
- “N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.” CNS Drugs.2015 Sep;29(9):801-9. 51237
Researcher Contact Information
Jerome Sarris, PhD, Department of Psychiatry, The Melbourne Clinic at The University of Melbourne, 2 Salisbury St Richmond, Melbourne, VIC, 3121, Australia, 011 +6140408 3393, firstname.lastname@example.org
The views, opinions and technical analyses presented here are those of the author, and are not necessarily those of UL, ULProspector.com or Knowledge.ULProspector.com. While the editors of this site make every effort to verify the accuracy of its content, we assume no responsibility for errors made by the author, editorial staff or any other contributor. All content is subject to copyright and may not be reproduced without prior authorization from Prospector.